FLT3

Molecular response to gilteritinib, a FLT3 inhibitor, in R/R AML, FLT3+

Anne Villeneuve | Jun 8, 2017 | Expert Opinion

L:

2017 ASCO Annual Meeting - 2-6 June, Chicago

Our partners

Our supporters

Platinum

Silver

Bronze

Bronze

Bronze

Our contributors